Citadel Advisors
ELVN icon

Citadel Advisors’s Enliven Therapeutics ELVN Stock Holding History

Citadel Advisors’s Portfolio ELVN Stock Details ELVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.42M Buy
+36,100
New +$1M ﹤0.01% 6851
2025
Q2 		– Sell
-200
Closed -$3.94K – 13225
2025
Q1 		$3.94K Sell
200
-900
-82% -$19.4K ﹤0.01% 13928
2024
Q4 		$24.8K Buy
1,100
+1,000
+1,000% +$25.9K ﹤0.01% 13036
2024
Q3 		$2.55K Sell
100
-3,500
-97% -$81.1K ﹤0.01% 13738
2024
Q2 		$84.1K Buy
+3,600
New +$75.8K ﹤0.01% 11153
2023
Q4 		– Sell
-175
Closed -$2.39K – 14519
2023
Q3 		$2.39K Hold
175
– – ﹤0.01% 13728
2023
Q2 		$3.57K Sell
175
-2,350
-93% -$47.5K ﹤0.01% 13681
2023
Q1 		$55.3K Sell
2,525
-4,900
-66% -$99.7K ﹤0.01% 12028
2022
Q4 		$121K Sell
7,425
-250
-3% -$4K ﹤0.01% 10940
2022
Q3 		$70K Buy
+7,675
New +$45.3K ﹤0.01% 11384

Other funds holding ELVN

O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $22.9B AUM 115.26% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return